Development of a highly sensitive electrochemical sensing platform for the trace level detection of lead ions.

Herein we report for the first time a highly sensitive electrochemical platform for the trace level detection of Pb (ӏӏ) using glassy carbon electrode modifiedwith 1-dodecanoyl-3-phenylthiourea (DPT). The performance of the designed sensor was tested by electrochemical impedance spectroscopy, chronocoulometry, cyclic voltammetry and Square Wave Anodic Stripping Voltammetry (SWASV). The DPT was found to play an efficient role in enhancing the sensing response of the electrode for the detection of lead ions in aqueous samples. A number of experimental conditions such as deposition potential, accumulation time, surfactant concentration, pH, number of scans and supporting electrolytes were examined to optimize conditions for getting intense signal of the target analyte. Linear calibration curve was obtained using SWAS voltammetric data obtained under optimized conditions. The limit of detection with a value of 0.695 μg/L suggests that the designed sensor can sense lead ions even below the permissible concentration level (10 μg/L) recommended by the World Health Organization and Environmental Protection Agency of USA. The designed sensor demonstrated sensitivity, selectivity and stability for the targeted analyte. Percentage recoveries from real water samples with standard deviations of less than 2% suggested precision of the proposed method. Moreover, computational findings supported the experimental outcomes

Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial

Background Post-partum haemorrhage is the leading cause of maternal death worldwide. Early administration of tranexamic acid reduces deaths due to bleeding in trauma patients. We aimed to assess the effects of early administration of tranexamic acid on death, hysterectomy, and other relevant outcomes in women with post-partum haemorrhage. Methods In this randomised, double-blind, placebo-controlled trial, we recruited women aged 16 years and older with a clinical diagnosis of post-partum haemorrhage after a vaginal birth or caesarean section from 193 hospitals in 21 countries. We randomly assigned women to receive either 1 g intravenous tranexamic acid or matching placebo in addition to usual care. If bleeding continued after 30 min, or stopped and restarted within 24 h of the first dose, a second dose of 1 g of tranexamic acid or placebo could be given. Patients were assigned by selection of a numbered treatment pack from a box containing eight numbered packs that were identical apart from the pack number. Participants, care givers, and those assessing outcomes were masked to allocation. We originally planned to enrol 15 000 women with a composite primary endpoint of death from all-causes or hysterectomy within 42 days of giving birth. However, during the trial it became apparent that the decision to conduct a hysterectomy was often made at the same time as randomisation. Although tranexamic acid could influence the risk of death in these cases, it could not affect the risk of hysterectomy. We therefore increased the sample size from 15 000 to 20 000 women in order to estimate the effect of tranexamic acid on the risk of death from post-partum haemorrhage. All analyses were done on an intention-to-treat basis. This trial is registered with ISRCTN76912190 (Dec 8, 2008); ClinicalTrials.gov, number NCT00872469; and PACTR201007000192283. Findings Between March, 2010, and April, 2016, 20 060 women were enrolled and randomly assigned to receive tranexamic acid (n=10 051) or placebo (n=10 009), of whom 10 036 and 9985, respectively, were included in the analysis. Death due to bleeding was significantly reduced in women given tranexamic acid (155 [1·5%] of 10 036 patients vs 191 [1·9%] of 9985 in the placebo group, risk ratio [RR] 0·81, 95% CI 0·65–1·00; p=0·045), especially in women given treatment within 3 h of giving birth (89 [1·2%] in the tranexamic acid group vs 127 [1·7%] in the placebo group, RR 0·69, 95% CI 0·52–0·91; p=0·008). All other causes of death did not differ significantly by group. Hysterectomy was not reduced with tranexamic acid (358 [3·6%] patients in the tranexamic acid group vs 351 [3·5%] in the placebo group, RR 1·02, 95% CI 0·88–1·07; p=0·84). The composite primary endpoint of death from all causes or hysterectomy was not reduced with tranexamic acid (534 [5·3%] deaths or hysterectomies in the tranexamic acid group vs 546 [5·5%] in the placebo group, RR 0·97, 95% CI 0·87-1·09; p=0·65). Adverse events (including thromboembolic events) did not differ significantly in the tranexamic acid versus placebo group. Interpretation Tranexamic acid reduces death due to bleeding in women with post-partum haemorrhage with no adverse effects. When used as a treatment for postpartum haemorrhage, tranexamic acid should be given as soon as possible after bleeding onset. Funding London School of Hygiene & Tropical Medicine, Pfizer, UK Department of Health, Wellcome Trust, and Bill & Melinda Gates Foundation

Impact of COVID-19 on cardiovascular testing in the United States versus the rest of the world

Objectives: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-US institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic. Background: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality. Methods: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States. Results: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p < 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis. Conclusions: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection

Effect of Garcinia Cambogia Containing Co;mmercially Avaible Weight Reducing Agent on Morphology of Hepatocytes An Experimental Study

Background and Objective: Obesity is the adverse outcome of modern living which has affected both the physical and mental health. Slim Smart and Ultra Slim Plus are the most frequently purchased over the counter products by desperate obese persons in Pakistan having Garcinia cambogia (GC) as the main active ingredient. This study is conducted to determine the effect of GC containing Slim Smart and Ultra Slim Plus drugs on the morphology of hepatocytes in male albino mice. Methods: Ninety albino mice were divided into control group A, experimental groups B and C receiving Slim Smart and Ultra Slim Smart respectively. Each group was further divided into subgroup I and II and the drug was administered to experimental groups for 4 and 8 weeks respectively via oral gavage. After the completion of experiment, histological examination of liver was conducted. Results: Marked enlargement of hepatocytes was observed in experimental groups B and C (both I &amp; II) along with ballooning degeneration and fatty change in the cytoplasm. Conclusion: Both Slim Smart and Ultra Slim Plus has hepatotoxic effects resulting in increase in hepatocyte size, ballooning degeneration and fatty change in liver cells.&nbsp;</p

Preparation and characterization of pH sensitive crosslinked Linseed polysaccharides-co-acrylic acid/methacrylic acid hydrogels for controlled delivery of ketoprofen

Some pH responsive polymeric matrix of Linseed (Linum usitatissimum), L. hydrogel (LSH) was prepared by free radical polymerization using potassium persulfate (KPS) as an initiator, N,N-methylene bisacrylamide (MBA) as a crosslinker, acrylic acid (AA) and methacrylic acid (MAA) as monomers; while ketoprofen was used as a model drug. Different formulations of LSH-co-AA and LSH-co-MAA were formulated by varying the concentration of crosslinker and monomers. Structures obtained were thoroughly characterized using Fourier transforms infrared (FTIR) spectroscopy, XRD analysis and Scanning electron microscopy. Sol-gel fractions, porosity of the materials and ketoprofen loading capacity were also measured. Swelling and in vitro drug release studies were conducted at simulated gastric fluids, i.e., pH 1.2 and 7.4. FTIR evaluation confirmed successful grafting of AA and MAA to LSH backbone. XRD studies showed retention of crystalline structure of ketoprofen in LSH-co-AA and its amorphous dispersion in LSH-co-MAA. Gel content was increased by increasing MBA and monomer content; whereas porosity of hydrogel was increased by increasing monomer concentration and decreased by increasing MBA content. Swelling of copolymer hydrogels was high at pH 7.4 and low at pH 1.2. Ketoprofen release showed an increasing trend by increasing monomer content; however it was decreased with increasing MBA content. Sustained release of ketoprofen was noted from copolymers and release followed Korsmeyer-Peppas model

Carbon-based sorbets for heavy metal removal from aqueous solution, discrepancies, and future prospects: a state-of-the-art review

Heavy metal contamination is severely affecting human health and environment. These metals are known to exist naturally but the anthropogenic activities have contributed towards increasing their concentrations beyond permissible limits, which in turn have proved to be hazardous for the human health as well as environment. Various industries release the untreated wastewater containing heavy metals into the open streams, thereby creating a contaminated source affecting negatively on consumers. In order to deal with this, several materials have been researched and proposed as adsorbents to remove these contaminants. Amongst them are carbon-based materials, that have shown to be effective, efficient, and environment-friendly option for heavy metal adsorption from aqueous solutions. The present review thoroughly summarizes the recent developments of carbon-based materials, specifically in terms of their application in heavy metal removal from aqueous solutions. Moreover, it elaborates the adsorption mechanism and compares it with other technologies available for metallic removal. Similarly, various parameters affecting the adsorption using carbon-based materials and their recent regenerative strategies are presented. In the end, numerous shortcomings and discrepancies associated with carbon-based materials are given along with their future prospects that need to be addressed in the upcoming research.Fil: Akhter, Faheem. No especifíca;Fil: Miranda Zoppas, Fernanda. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe. Instituto de Investigaciones en Catálisis y Petroquímica "Ing. José Miguel Parera". Universidad Nacional del Litoral. Instituto de Investigaciones en Catálisis y Petroquímica "Ing. José Miguel Parera"; ArgentinaFil: Soomro, Mehran. Mehran University Of Engineering & Technology; PakistánFil: Sattar Jatoi, Abdul. Dawood University Of Engineering & Technology; PakistánFil: Noureen, Fozia. No especifíca;Fil: Naeem Akhtar, Muhammad. Beijing Institute Of Technology,; ChinaFil: Mehreen, Faiza. Mehran University Of Engineering & Technology; Pakistá

Effect of IL-28 B Polymorphisms on Early Virological Response (EVR) in Chronic Hepatitis C Patients Treated with Interferon and Ribavirin

Background: To determine the frequency of EVRin chronic hepatitis C (CHC) patients treated withInterferon and Ribavirin and to compare the effect ofIL-28B SNP rs12979860 (CC and non CC genotypes)on frequency of EVR.Methods: In this cross-sectional study 100 patientswith Chronic Hepatitis C (CHC) with genotype 3who received Interferon and Ribavirin in thestandard doses were categorized in two groupsdepending upon the IL-28B SNP rs12979860 CC andnon CC genotypes. Results of Qualitative PCR forHCV RNA after 12 weeks of treatment and EVRwere entered. Frequency of EVR in the two groups(CC and non CC) was compared.Results: Among the 100 patients with ChronicHepatitis C treated with Interferon and Ribavirin, 72patients achieved EVR (72%). Out of the 100patients, 52 had CC genotype and 48 had non-CCgenotype (40 with CT and 8 with TT genotype). Inthe CC group 47 out of 52 patients achieved EVR(90%) while in the non-CC group 25 out of 48patients achieved EVR (52%). The p value in ourstudy was 0.00Conclusion: The frequency of EVR is 72% inChronic Hepatitis C patients infected with genotype3 treated with Interferon and Ribavirin which iscomparable with Pegylated Interferon and Ribavirin.Patients with IL-28B SNP rs12979860 CC genotypehave a better chance to achieve EVR (90%) ascompared to the non-CC genotype (52%)

Synthesis, characterization and biological properties of novel ON donor bidentate Schiff bases and their copper(II) complexes

<p>Four novel ON donor Schiff bases (E)-3-((4-phenoxyphenylimino)methyl)benzene-1,2-diol (HL₁),(E)-3-((4-(4-biphenyloxy)phenyliminomethyl)benzene-1,2-diol (HL₂), (E)-3-((4-naphthoxyphenylimino)methyl)benzene-1,2-diol (HL₃), (E)-3-((4-(2-naphthoxy)phenylimino)methyl)benzene-1,2-diol (HL₄) and their copper(II) complexes bis((E)-3-((4-phenoxyphenylimino)methyl)benzene-1,2-diol) copper(II) (Cu(L₁)₂) bis((E)-3-((4-(4-biphenyloxy)phenylimino)methyl)benzene-1,2-diol) copper(II) (Cu(L₂)₂), bis((E)-3-((4-naphthoxyphenylimino)methyl)benzene-1,2-diol) copper(II) (Cu(L₃)₂), bis((E)-3-((4-(2-naphthoxy)phenylimino)methyl)benzene-1,2-diol) copper(II) (Cu(L₄)₂) have been synthesized and characterized by spectroscopic (FTIR, NMR, UV–visible) and elemental analysis. The crystal structures of HL₁, HL₂, HL₃_, and HL₄ have been determined, which reveal intramolecular N-H⋯O (HL₁, HL₂, HL₃_, and HL₄) hydrogen bonds in the solid state. Keto-amine and enol-imine tautomerism is exhibited by the Schiff bases in solid and solution states. The Schiff bases and their copper(II) complexes have been screened for their biological activities. In antimicrobial assays (antibacterial and antifungal), HL₄ showed promising results against all strains through dual inhibition property while the rest of the compounds showed activity against selective strains. On the other hand, in cytotoxic, DPPH, and inhibition of hydroxyl (OH) free radical-induced DNA damage assays, the results were found significantly correlated with each other, <i>i.e.</i> the ligands HL₁ and HL₂ showed moderate activity while their complexes Cu(L₁)₂ and Cu(L₂)₂ exhibited prominent increase in activity. As the results of these assays are supporting each other, it represents the strong positive correlation and antioxidant nature of investigated compounds.</p